We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » First Pharma Exec to Be Excluded by OIG Resigns
First Pharma Exec to Be Excluded by OIG Resigns
November 17, 2010
The former CEO and chairman of the board of KV Pharmaceutical has become the first pharmaceutical company executive to be excluded from participation in federal healthcare programs under a new HHS Office of Inspector General (OIG) guidance.